← Leaderboards
Carolyn Louise Cannon
Brigham And Women'S Hospital
$2,636,299
Attributed
$2,636,299
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $369.1K · FY2006–25$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,636,299 · 4
By mechanism
R01$1,080,876 · 1
K08$607,048 · 1
R25$540,000 · 1
R21$408,375 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Y. Shrike Zhang$13,550,158
- Ali Tamayol$3,768,258
- Susan S Redline$76,698,471
- James Kuang-Jan Liao$22,168,806
Others in their field
Top investigators on “Pseudomonas Aeruginosa”
- Henry F Chambers · Duke University$46,515,637
- Vance G Fowler · Duke University$46,515,637
- Deborah T Hung · Massachusetts General Hospital$24,051,776
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Daniel J Wozniak · Ohio State University$19,184,613
- Alan R Hauser · Northwestern University$18,516,245
Research focus
Pseudomonas AeruginosaCystic FibrosisConfocal Scanning MicroscopyGene ExpressionFlow CytometryCysteine EndopeptidasesRespiratory EpitheliumChloride ChannelsTissue /Cell CultureLaboratory MouseMicroarray TechnologyPathologic ProcessRespiratory InfectionsApoptosisTerminal Nick End LabelingAntimicrobial DrugMulti-Drug ResistanceAntimicrobialLaboratoriesInfectionIn VitroEngineeringBaseIn Vivo
Grant awards (12)
TREX:Texas Research Experience Experiment$270,000
R25 · FY2025 · GM · contact PI
TREX:Texas Research Experience Experiment$270,000
R25 · FY2024 · GM · contact PI
Antimicrobial, anti-inflammatory, analgesic, silver-based, electrospun bandages for superior wound healing$222,750
R21 · FY2020 · AI · contact PI
Antimicrobial, anti-inflammatory, analgesic, silver-based, electrospun bandages for superior wound healing$185,625
R21 · FY2019 · AI · contact PI
Silver carbene complexes as treatment of CF lung disease$357,064
R01 · FY2008 · AI · contact PI
Silver carbene complexes as treatment of CF lung disease$354,691
R01 · FY2007 · AI · contact PI
Silver carbene complexes as treatment of CF lung disease$369,121
R01 · FY2006 · AI · contact PI
THE ROLE OF APOPTOSIS IN CF PSEUDOMONAL LUNG INFECTION$118,317
K08 · FY2004 · HL
THE ROLE OF APOPTOSIS IN CF PSEUDOMONAL LUNG INFECTION$118,316
K08 · FY2003 · HL
THE ROLE OF APOPTOSIS IN CF PSEUDOMONAL LUNG INFECTION$125,228
K08 · FY2002 · HL
THE ROLE OF APOPTOSIS IN CF PSEUDOMONAL LUNG INFECTION$125,167
K08 · FY2001 · HL
THE ROLE OF APOPTOSIS IN CF PSEUDOMONAL LUNG INFECTION$120,020
K08 · FY2000 · HL